IN2015DN02929A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02929A
IN2015DN02929A IN2929DEN2015A IN2015DN02929A IN 2015DN02929 A IN2015DN02929 A IN 2015DN02929A IN 2929DEN2015 A IN2929DEN2015 A IN 2929DEN2015A IN 2015DN02929 A IN2015DN02929 A IN 2015DN02929A
Authority
IN
India
Prior art keywords
luliconazole
solubility
atoms
improving
disclosed
Prior art date
Application number
Other languages
English (en)
Inventor
Takaaki; Masuda
Makoto; Gotoh
Yoshiyuki; Miyata
Original Assignee
Pola Pharma Inc
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc, Nihon Nohyaku Co Ltd filed Critical Pola Pharma Inc
Publication of IN2015DN02929A publication Critical patent/IN2015DN02929A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN2929DEN2015 2012-09-14 2013-09-06 IN2015DN02929A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012202514 2012-09-14
JP2013131504 2013-06-24
PCT/JP2013/074775 WO2014042231A1 (en) 2012-09-14 2013-09-06 Crystal and pharmaceutical preparation containing the same crystal

Publications (1)

Publication Number Publication Date
IN2015DN02929A true IN2015DN02929A (ru) 2015-09-18

Family

ID=49237577

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2929DEN2015 IN2015DN02929A (ru) 2012-09-14 2013-09-06

Country Status (7)

Country Link
US (1) US9012484B2 (ru)
EP (1) EP2895165B1 (ru)
JP (1) JP5589130B1 (ru)
CN (1) CN104284662A (ru)
IN (1) IN2015DN02929A (ru)
RU (1) RU2622644C2 (ru)
WO (1) WO2014042231A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
JP5688405B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
EP2470178B1 (en) 2009-08-25 2018-10-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101806304B1 (ko) 2010-06-11 2017-12-07 가부시키가이샤 폴라 파마 항진균성 약학적 조성물
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
RU2603963C2 (ru) 2012-09-14 2016-12-10 Пола Фарма Инк. Кристалл, обладающий кристаллическими габитусами, и фармацевтическая композиция, полученная обработкой данного кристалла
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) * 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
EP3230280A4 (en) * 2014-12-12 2018-05-09 Glenmark Pharmaceuticals Limited Process for preparation of luliconazole
JP5951864B1 (ja) * 2015-06-05 2016-07-13 株式会社ポーラファルマ 抗ジアルジア剤
JP2017101009A (ja) 2015-12-04 2017-06-08 株式会社ポーラファルマ 抗アカントアメーバ剤及びその製造法
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
JP7315055B1 (ja) 2022-03-16 2023-07-26 カシオ計算機株式会社 電子機器

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
GB2317615B (en) * 1995-07-08 1998-09-02 Nihon Nohyaku Co Ltd Antifungal agent compound therefor process for producing the same
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
NZ571819A (en) 2006-03-08 2011-04-29 Nihon Nohyaku Co Ltd External pharmaceutical composition comprising luliconazole and either N-methyl-2-pyrrolidone, propylene carbonate or crotamiton
MX2008011433A (es) 2006-03-08 2008-09-18 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
CA2645110C (en) 2006-03-08 2013-11-19 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
WO2009031644A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌医薬組成物
KR20100075476A (ko) 2007-09-05 2010-07-02 가부시키가이샤 폴라 파마 항진균 조성물
US20100204293A1 (en) 2007-09-05 2010-08-12 Pola Pharma Inc. Pharmaceutical composition
EP2745692A1 (en) 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc anti-fungal formulation containing luliconazole
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
JP5688405B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
EP2470178B1 (en) 2009-08-25 2018-10-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101806304B1 (ko) 2010-06-11 2017-12-07 가부시키가이샤 폴라 파마 항진균성 약학적 조성물
US8728210B2 (en) 2011-07-07 2014-05-20 Hsueh Yuan Lee Exhaust gas treatment apparatus and method
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
RU2603963C2 (ru) 2012-09-14 2016-12-10 Пола Фарма Инк. Кристалл, обладающий кристаллическими габитусами, и фармацевтическая композиция, полученная обработкой данного кристалла
JP5686874B2 (ja) 2012-09-14 2015-03-18 株式会社ポーラファルマ 医薬組成物
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物

Also Published As

Publication number Publication date
US9012484B2 (en) 2015-04-21
EP2895165A1 (en) 2015-07-22
RU2015113638A (ru) 2016-11-10
JP5589130B1 (ja) 2014-09-10
CN104284662A (zh) 2015-01-14
US20140080882A1 (en) 2014-03-20
JP2015027972A (ja) 2015-02-12
RU2622644C2 (ru) 2017-06-19
WO2014042231A1 (en) 2014-03-20
EP2895165B1 (en) 2016-12-14

Similar Documents

Publication Publication Date Title
IN2015DN02929A (ru)
PH12016500611A1 (en) Compositions useful for treating disorders related to kit
PH12016501375A1 (en) Pyridin-2-amides useful as cb2 agonists
IN2015DN02376A (ru)
UA114656C2 (uk) Похідні піридину
CO7111289A2 (es) Compuestos inhibidores de metaloenzimas
UA110471C2 (ru) 5-алкінілпіримідини
SG10201805410XA (en) Therapeutic agent or prophylactic agent for dementia
UA114655C2 (uk) Піридин-2-аміди, придатні як агоністи канабіноїдного рецептора 2
MX363727B (es) Nuevos derivados de pirazol.
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
MY179412A (en) Pyridine-2-amides useful as cb2 agonists
IN2014DN09085A (ru)
PH12015501933A1 (en) Novel pyridine derivatives
MX2013015308A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
IN2015DN03928A (ru)
UA116654C2 (uk) Похідні пурину як агоністи канабіноїдного рецептора св2
IN2013DE00266A (ru)
GEP201706626B (en) Synthesis of (s)-nifuratel
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
AU2014371081A1 (en) Polyoxalates and a Process for the Production Thereof
MX2014008918A (es) Nuevos derivados de pirrolidina.
AU2013347232A8 (en) 3-Aminocyclopentane carboxamide derivatives
IN2014DN10658A (ru)
IN2014DN08443A (ru)